MEBOC
Asset Logo

Medibio Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-21.68%
Annual Growth

3 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Medibio Limited - Option Expiring 28-Feb-2024

📈 Performance

Price History

-75.00%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.00

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in MEBOC

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in MEBOC

N/A
MEBOC investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in MEBOC also invest in...

Want more shares? Try these...

Morphic Ethical Equities Fund Limited

MEC

Morphic Ethical Equities Fund Ltd is a AU-based company operating in Capital Markets industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-05-03. Morphic Ethical Equities Fund Limited is an investment company. The Company’s principal activity is investing in global listed securities screened to exclude entities involved in environmentally damaging activities (including coal and uranium, mining and oil and gas), intensive farming and aquaculture, tobacco, armaments, alcohol and gambling. The Company’s investment objectives are to deliver investors an ethically screened portfolio; generate superior risk-adjusted returns; and provide capital growth and consistent income. The firm primarily invests in global listed securities. The firm may also invest in unlisted securities, fixed interest instruments, commodities, credit instruments and currencies, all of which may be invested through assets, Exchange Traded Funds or other Derivatives, including futures, options, forwards and swaps. Morphic Asset Management Pty Limited is the Company's investment manager.

📊 Share price

$0.94 AUD
Find Out More

Megado Minerals Ltd. engages in gold exploration. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-10-27. The Company’s assets include the North Fork Rare Earth Project in Idaho, the United States of America and the Cyclone Lithium Project in the James Bay region in Quebec, Canada. The Company’s projects include North Fork Project and Cyclone Lithium Project. North Fork Rare Earth Project (North Fork), located in the Idaho Cobalt Belt region of Idaho, the United States of America. North Fork consists of over 526 (granted and in application), covering approximately 45 square kilometers (km2) with outcropping, high-grade, rare-earth element (REE) mineralized rock. The Cyclone Project is in Quebec’s James Bay region and centered on the Aquilon Greenstone. The Project encompasses 130 km2 and includes approximately 304 claims. The Cyclone Project is within the La Grande Sub province and includes two folded Greenstone belts, which include the northern La Forge Greenstone Belt and the southern Aquilon Greenstone Belt.

📊 Share price

$0.05 AUD

McGrath Ltd. engages in the provision of residential real estate services, which includes residential property sales, property management, mortgage broking, auction services, and real estate training. The company is headquartered in Sydney, New South Wales and currently employs 273 full-time employees. The company went IPO on 2015-12-07. The firm is engaged in providing residential property sales, property management, residential project marketing, mortgage broking, auction services and career training. The Company’s segments include Company owned sales, Company owned property management, Franchise services, and Other services and investments. The firm owned sales segment undertakes residential property sales on behalf of property vendors through Company owned offices and agents. The firm owned property management segment directly manages residential properties on behalf of owner’s clients. The Franchise services segment manages franchise offices that undertake both property sales and property management activities. The Other services and investments segment has several other services and investments, which complement the service offerings of the segments. Its services include projects, new land estates, rural and livestock and home loans.

📊 Share price

$0.40 AUD

Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. The company is focused on early detection and screening of mental health conditions. Through their Corporate Health product, the Company offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company has launched its consumer mobile app to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allow consumers to monitor their daily stress levels through their own personal wearable device and provides science-based learning modules to help manage their stress.

📊 Share price

$0.00 AUD
Compare
Add to watchlist